VANCOUVER, BC, CANADA & SAN DIEGO, CA, USA, Sept. 26 /CNW/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, will make a presentation at the UBS 2006 Global Life Sciences Conference being held in New York City September 25-28, 2006. Dr. Jim DeMesa, President and Chief Executive Officer, will present a corporate overview on September 28th at 11:30am (ET) in Ballroom A of the Grand Hyatt New York. A webcast of the presentation will be available by registering at www.ibb.ubs.com (click on “Conferences” box and then “Webcast” for the September 25-28 conference) and a copy of the presentation will be available on the Company’s web site at www.migenix.com the day of the presentation.
